- Business Model
- B2B
- Website
- harvestiro.com
- Last Round
- Series AJan 2024
- Rounds
- 1
About
Full-service global clinical research organization (CRO) delivering end-to-end clinical trial services including regulatory strategy, clinical data science, and medical monitoring.
Summary
HIRO is a Biotech company. Its most recent funding was a Series A round in Jan 2024. Investors include OrbiMed.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...